The Production and Delivery of Probiotics: A Review of a Practical Approach
- PMID: 30884906
- PMCID: PMC6463069
- DOI: 10.3390/microorganisms7030083
The Production and Delivery of Probiotics: A Review of a Practical Approach
Abstract
To successfully deliver probiotic benefits to the consumer, several criteria must be met. Here, we discuss the often-forgotten challenges in manufacturing the strains and incorporating them in consumer products that provide the required dose at the end of shelf life. For manufacturing, an intricate production process is required that ensures both high yield and stability and must also be able to meet requirements such as the absence of specific allergens, which precludes some obvious culture media ingredients. Reproducibility is important to ensure constant high performance and quality. To ensure this, quality control throughout the whole production process, from raw materials to the final product, is essential, as is the documentation of this quality control. Consumer product formulation requires extensive skill and experience. Traditionally, probiotic lactic acid bacteria and bifidobacteria have been incorporated in fermented dairy products, with limited shelf life and refrigerated storage. Currently, probiotics may be incorporated in dietary supplements and other "dry" food matrices which are expected to have up to 24 months of stability at ambient temperature and humidity. With the right choice of production process, product formulation, and strains, high-quality probiotics can be successfully included in a wide variety of delivery formats to suit consumer requirements.
Keywords: Bifidobacterium; Lactobacillus; manufacturing; probiotics; strain stability.
Conflict of interest statement
At the time of writing, all authors were employed by DuPont Nutrition and Health. DuPont Nutrition and Health manufactures and markets probiotics.
Figures
References
-
- FAO/WHO Guidelines for the Evaluation of Probiotics in Food. [(accessed on 16 March 2019)];2002 :1–11. Available online: https://www.who.int/foodsafety/fs_management/en/probiotic_guidelines.pdf.
-
- Hill C., Guarner F., Reid G., Gibson G.R., Merenstein D.J., Pot B., Morelli L., Canani R.B., Flint H.J., Salminen S., et al. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat. Rev. Gastroenterol. Hepatol. 2014;11:506–514. doi: 10.1038/nrgastro.2014.66. - DOI - PubMed
-
- Johnston B.C., Lytvyn L., Lo C.K., Allen S.J., Wang D., Szajewska H., Miller M., Ehrhardt S., Sampalis J., Duman D.G., et al. Microbial preparations (probiotics) for the prevention of clostridium difficile infection in adults and children: An individual patient data meta-analysis of 6851 participants. Infect. Control Hosp. Epidemiol. 2018;39:771–781. doi: 10.1017/ice.2018.84. - DOI - PubMed
-
- Morovic W., Roper J.M., Smith A.B., Mukerji P., Stahl B., Rae J.C., Ouwehand A.C. Safety evaluation of HOWARU((R)) restore (Lactobacillus acidophilus NCFM, Lactobacillus paracasei Lpc-37, Bifidobacterium animalis subsp. lactis Bl-04 and B. lactis Bi-07) for antibiotic resistance, genomic risk factors, and acute toxicity. Food Chem. Toxicol. 2017;110:316–324. doi: 10.1016/j.fct.2017.10.037. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
